Pulse Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Pulse Biosciences

31/03/2022 23:38

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly
adjusted
loss of 52 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 51 cents per share.
    * Revenue was $884.00 thousand​;  analysts expected $872.00
thousand. 
    * Pulse Biosciences Inc's reported EPS for the quarter was a
loss
of 52 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulse Biosciences Inc shares had fallen by 66.5% this
quarter.
    * The company reported a quarterly loss of $15.42 million.
    * Wall Street's median 12-month price target for Pulse
Biosciences
Inc is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 31 at 10:38 p.m.  ​All
figures in US dollars unless otherwise stated